Kimberly-Clark Takeover Offers $48 Billion of Pain Relief to Tylenol-Maker Kenvue

The deal, expected to close in the second half of 2026, comes as Kenvue's Tylenol political fight is heating up.

Tylenol, Kleenex, Band-Aid and More Put Under One Roof in $48.7 Billion Consumer Brands Deal

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company ...
Cryptopolitan on MSN

Asian stock markets show split results as AI excitement drives Wall Street

Asian markets showed mixed results with Japan, Australia, and South Korea posting losses while Hong Kong gained slightly ...
The Manila Times on MSN

Kimberly-Clark to buy Tylenol maker Kenvue in $48.7-B deal

KIMBERLY-CLARK is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54 ...